Structural Mechanisms of PTEN Regulation

Published on Mar 1, 2020in Cold Spring Harbor Perspectives in Medicine6
· DOI :10.1101/CSHPERSPECT.A036152
Glenn R. Masson16
Estimated H-index: 16
(LMB: Laboratory of Molecular Biology),
Roger L. Williams82
Estimated H-index: 82
(LMB: Laboratory of Molecular Biology),
Roger Williams2
Estimated H-index: 2
(LMB: Laboratory of Molecular Biology)
Sources
Abstract
The tumor suppressor phosphatase and tensin homolog on chromosome 10 (PTEN) is a tightly regulated enzyme responsible for dephosphorylating the progrowth lipid messenger molecule phosphatidylinositol 3,4,5-trisphosphate (PIP3) on the plasma membrane. The carboxy-terminal tail (CTT) of PTEN is key for regulation of the enzyme. When phosphorylated, the unstructured CTT interacts with the phosphatase-C2 superdomain to inactivate the enzyme by preventing membrane association. PTEN mutations associated with cancer also inactivate the enzyme. Alternate translation-initiation sites generate extended isoforms of PTEN, such as PTEN-L that has multiple roles in cells. The extended amino-terminal region bears a signal sequence and a polyarginine sequence to facilitate exit from and entry into cells, respectively, and a membrane-binding helix that activates the enzyme. This amino-terminal region also facilitates mitochondrial and nucleolar localization. This review explores PTEN structure and its impact on localization and regulation.
📖 Papers frequently viewed together
516 Citations
20147.97Oncogene
6 Authors (Hoai-Nghia Nguyen, ..., Miho Iijima)
36 Citations
1 Citations
References3
Newest
#1Tatyana Tolkacheva (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 5
#2Manoranjan Boddapati (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 1
Last. Andrew M. Chan (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 57
view all 6 authors...
We have reported previously that the PTEN COOH-terminal 33 amino acids play a role in the maintenance of PTEN protein stability (Tolkacheva and Chan, Oncogene, 19: 680–689, 2000). By site-directed mutagenesis, we identified two threonine residues within this COOH-terminal region at codon 382 and 383 that may be targets for phosphorylation events. Interestingly, PTEN mutants rendered phosphorylation-incompetent at these two sites, T382A/T383A, and were found to have drastically reduced expression...
168 Citations
#2Kathrin H. KirschH-Index: 23
Last. Hidesaburo HanafusaH-Index: 96
view all 6 authors...
PTEN is a tumor suppressor frequently inactivated in brain, prostate, and uterine cancer. It acts as a phosphoinositide phosphatase and consists of an amino-terminal phosphatase domain tightly linked to a COOH-terminal C2 domain involved in lipid membrane-binding. We investigated the functions of the C2 domain and their relevance for tumor growth. To discriminate between PTEN C2 domain ability to recruit or to position the active site to the membrane, we artificially membrane-targeted PTEN by a ...
208 Citations
#1Nils Adey (Myriad Genetics)H-Index: 5
#1Nils B. Adey (Myriad Genetics)H-Index: 17
Last. Paul L. Bartel (Myriad Genetics)H-Index: 10
view all 8 authors...
Two-hybrid searches with the tumor suppressor MMAC1/PTEN isolated the proteins hDLG and hMAST205. Further two-hybrid analysis and microtiter plate binding assays localized the sites of interaction to PDZ domains from hDLG and hMAST205 and the PDZ binding domain at the COOH terminus of MMAC1/PTEN. A synthetic peptide derived from the MMAC1/PTEN PDZ binding domain (MMAC1/PTEN-PDZBD) was used to coprecipitate proteins from A431 human cell lysate. The recovered proteins were resolved by SDS-PAGE and...
196 Citations
Cited By9
Newest
#1Sabryn A. Hamila (Monash University, Clayton campus)H-Index: 1
#2Lisa M Ooms (Monash University, Clayton campus)H-Index: 22
Last. Christina Anne Mitchell (Monash University, Clayton campus)H-Index: 62
view all 0 authors...
Cancer is a complex and heterogeneous disease marked by the dysregulation of cancer driver genes historically classified as oncogenes or tumour suppressors according to their ability to promote or inhibit tumour development and growth, respectively. Certain genes display both oncogenic and tumour suppressor functions depending on the biological context, and as such have been termed dual-role cancer driver genes. However, because of their context-dependent behaviour, the tumourigenic mechanism of...
Source
Source
#1Rensiqin Wu (Inner Mongolia Medical University)
#2Hui Wang (Inner Mongolia Medical University)
Last. Rui Xiao (Inner Mongolia Medical University)
view all 4 authors...
Objective The purpose of this study was to explore the regulation of A-FABP-PTEN/AKT on insulin resistance in preadipocyte 3T3-L1 cell. Methods siRNA interference method was used to knock-down the A-FABP expression in 3T3-L1 cells. The cell proliferation was detected by oil-O staining and MTT. The protein and mRNA expression levels of A-FABP, PTEN and AKT were detected by Western blot and qPCR. Results Inhibition of A-FABP expression increased cell proliferation activity of the 3T3-L1 cells. Mor...
Source
#1Laura D'Andrea (Monash University, Clayton campus)H-Index: 3
#2Christina M. Lucato (Monash University, Clayton campus)H-Index: 2
Last. Andrew M. Ellisdon (Monash University, Clayton campus)H-Index: 19
view all 14 authors...
The dual-specificity phosphatase PTEN functions as a tumor suppressor by hydrolyzing PI(3,4,5)P3 to PI(4,5)P2 to inhibit PI3K-AKT signaling and cellular proliferation. P-Rex2 is a guanine nucleotide exchange factor for Rho GTPases and can be activated by Gβγ subunits downstream of G protein-coupled receptor signaling and by PI(3,4,5)P3 downstream of receptor tyrosine kinases. The PTEN:P-Rex2 complex is a commonly mutated signaling node in metastatic cancer. Assembly of the PTEN:P-Rex2 complex in...
Source
#1Hyunbum JangH-Index: 31
#2Iris Nira Smith (Cleveland Clinic Lerner Research Institute)H-Index: 2
Last. Ruth Nussinov (TAU: Tel Aviv University)H-Index: 124
view all 4 authors...
Summary Tumor suppressor PTEN, the second most highly mutated protein in cancer, dephosphorylates signaling lipid PIP3 produced by PI3Ks. Excess PIP3 promotes cell proliferation. The mechanism at the membrane of this pivotal phosphatase is unknown hindering drug discovery. Exploiting explicit solvent simulations, we tracked full-length PTEN trafficking from the cytosol to the membrane. We observed its interaction with membranes composed of zwitterionic phosphatidylcholine, anionic phosphatidylse...
Source
#1Ruth Nussinov (Leidos)H-Index: 124
#2Mingzhen Zhang (Leidos)H-Index: 31
Last. Hyunbum JangH-Index: 31
view all 4 authors...
PI3K and PTEN are the second and third most highly mutated proteins in cancer following only p53. Their actions oppose each other. PI3K phosphorylates signaling lipid PIP2 to PIP3. PTEN dephosphorylates it back. Driver mutations in both proteins accrue PIP3. PIP3 recruits Akt and PDK1 to the membrane, promoting cell cycle progression. Here we review phosphorylation events and mutations in autoinhibition in PI3K and PTEN from the structural standpoint. Our purpose is to clarify how they control t...
2 CitationsSource
#1Wanfu Wu (UH: University of Houston)H-Index: 16
#2Li Wang (UH: University of Houston)H-Index: 2
Last. Jan-Ake Gustafsson (UH: University of Houston)H-Index: 190
view all 8 authors...
Knockout of ERβ in the mouse leads to nuclear expression of epidermal growth factor receptor (EGFR) in the prostate. To examine whether ERβ plays a similar role in the human prostate, we used four cohorts of men: 1) a Swedish cohort of normal prostates and PCa (prostate cancer) of different Gleason grades; 2) men with benign prostatic hyperplasia (BPH) treated with the 5α-reductase inhibitor, finasteride, and finasteride together with the ERβ agonists, soy isoflavones; 3) men with PCa above Glea...
Source
#1Alexander N. R. Weber (University of Tübingen)H-Index: 32
#2Zsofia Bittner (University of Tübingen)H-Index: 6
Last. Ana Tapia-Abellán (University of Tübingen)H-Index: 10
view all 7 authors...
The NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome is a fascinating cellular machinery endowed with the capacity for rapid proteolytic processing of the pro-inflammatory cytokine IL-1β and the cell death effector gasdermin D (GSDMD). Although its activity is essential to fight infection and support tissue homeostasis, the inflammasome complex, which consists of the danger sensor NLRP3, the adaptor apoptosis-associated speck-like protein containing a CARD (ASC; also known as...
8 CitationsSource
#1Nicola Fusco (IEO: European Institute of Oncology)H-Index: 18
#2Elham Sajjadi (IEO: European Institute of Oncology)H-Index: 6
Last. Marco Invernizzi (University of Eastern Piedmont)H-Index: 18
view all 10 authors...
Alterations in the tumor suppressor phosphatase and tensin homolog (PTEN) occur in a substantial proportion of solid tumors. These events drive tumorigenesis and tumor progression. Given its central role as a downregulator of the phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway, PTEN is deeply involved in cell growth, proliferation, and survival. This gene is also implicated in the modulation of the DNA damage response and in tumor immune microenvironment modelin...
6 CitationsSource
#1Laura D'Andrea (Monash University)H-Index: 3
#2Christina M. Lucato (Monash University)H-Index: 2
Last. Andrew M. Ellisdon (Monash University)H-Index: 19
view all 12 authors...
The PTEN:P-Rex2 complex is one of the most commonly mutated signaling nodes in metastatic cancer. Assembly of the PTEN:P-Rex2 complex inhibits the activity of both proteins, and its dysregulation can drive PI3K-AKT signaling and cell proliferation. Here, using extensive crosslinking mass spectrometry and functional studies, we provide crucial mechanistic insights into PTEN:P-Rex2 complex assembly and co-inhibition. PTEN is anchored to P-Rex2 by interactions between the PTEN PDZ-BM tail and the s...
Source